International Clinical Trial: SPF of Unbound Sunscreen (JAN-2526-2352/1)

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/108892) titled 'SPF of Unbound Sunscreen (JAN-2526-2352/1)' on April 21.

Study Type: PMS

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: Unbound Lifestyle Private Limited

Intervention: Intervention1: Test Product: Sunscreen (JAN-2526-2352/1): Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour

Control Intervention1: Reference Sunscreen: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour



Recruitment Status...